Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06275789 · ClinicalTrials.gov registry record · NA
Mix of Demineralized Freeze-Dried Bone Allograft and Deproteinized Bovine Bone Mineral: a Possible Solution for Alveolar Ridge Preservation?
A NA study of Bone Graft and Alveolar Ridge Preservation, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06275789: Recruiting NA study of Bone Graft and Alveolar Ridge Preservation, sponsored by Nova Southeastern University.
NCT06275789 is a NA study of Bone Graft and Alveolar Ridge Preservation that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06275789, a NA study of Bone Graft and Alveolar Ridge Preservation, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare a new grafting material for alveolar ridge preservation to a commonly used and well studied material. Alveolar ridge dimensions as well as histology will be compared.
Primary Outcome
Soft and hard tissue horizontal dimensions of the alveolar ridge will be measured after extraction and 4 months later.
Conditions Studied
Interventions
- PROCEDURE Alveolar ridge preservation
Study Locations (1)
Florida
- Nova Southeastern University - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06275789 shows while recruiting
NCT06275789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Bone Graft appearing as the primary indexed condition, and to 1 intervention - of which Alveolar ridge preservation is the first listed.
NCT06275789 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06275789 about?
NCT06275789 is a clinical study titled "Mix of Demineralized Freeze-Dried Bone Allograft and Deproteinized Bovine Bone Mineral: a Possible Solution for Alveolar Ridge Preservation?". The purpose of the study is to compare a new grafting material for alveolar ridge preservation to a commonly used and well studied material. Alveolar ridge dimensions as well as histology will be compared.
What is the current status of trial NCT06275789?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-01-26. Estimated completion is 2026-06.
What conditions does trial NCT06275789 study?
This clinical trial studies the following conditions: Bone Graft, Alveolar Ridge Preservation, Dental Extraction.
What interventions are being tested in trial NCT06275789?
The interventions under investigation include: Alveolar ridge preservation (PROCEDURE).
Who is sponsoring clinical trial NCT06275789?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06275789 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Graft
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06275789's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI